Tracheobronchitis
Mostrando 13-16 de 16 artigos, teses e dissertações.
-
13. Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds.
The prophylactic activity of intranasal human interferon-alpha 2 (HuIFN-alpha 2) against natural rhinovirus colds was determined in a randomized, double-blind, placebo-controlled trial. A total of 304 working adults self-administered sprays of HuIFN-alpha 2 (10(7) IU/day) or a placebo once daily. During 22 days of treatment, 13 (8.5%) placebo recipients but
-
14. Clinical and Laboratory Evaluation of Cefamandole in the Therapy of Haemophilus spp. Bronchopulmonary Infections
A prospective, randomized, single-blind comparison of parenteral cefamandole and ampicillin was conducted in 27 hospitalized adult patients with pneumonia or purulent tracheobronchitis due to Haemophilus spp. Patients received either parenteral cefamandole or ampicillin in a dose of 1 g every 6 h. Cefamandole was as effective and safe as ampicillin. Of the 1
-
15. Influenza virus infection of tracheal gland cells in culture.
Influenza virus-induced tracheobronchitis causes limited epithelial deciliation but markedly decreased mucociliary transport. This suggests that virus-induced alterations in airway mucus play a role in decreased mucociliary transport. Airway submucosal glands are a primary source of mucus. Therefore, we examined virus-gland cell interactions by exposing prim
-
16. Regulation of Proinflammatory Cytokines in Human Lung Epithelial Cells Infected with Mycoplasma pneumoniae
Mycoplasma pneumoniae is a small bacterium without a cell wall that causes tracheobronchitis and atypical pneumonia in humans. It has also been associated with chronic conditions, such as arthritis, and extrapulmonary complications, such as encephalitis. Although the interaction of mycoplasmas with respiratory epithelial cells is a critical early phase of pa
American Society for Microbiology.